Serina Therapeutics SER
NYSE SER
$1.51 +0.08 (+5.59%)
As of: Nov 11, 2026 · 3:59 PM EST

Serina Therapeutics (SER) Long-Term Debt Repayments (2023 - 2024)

Updated

Analysis

Serina Therapeutics (SER) Long-Term Debt Repayments (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Serina Therapeutics 23.59 Mn -35.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Sep 30, 2024 8,000.00
Jun 30, 2024 146,000.00
Mar 31, 2024 13,000.00
Dec 31, 2023 13,000.00
Sep 30, 2023 12,000.00
Jun 30, 2023 12,000.00
Mar 31, 2023 11,000.00
API Access

Serina Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SER&period=max&api_key=YOUR_API_KEY